CORC

在结果中检索

CORC

浏览/检索结果: 共74条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Operation Status of CSNS/RCS Transverse Collimation System 会议论文
Brazil, 2021
作者:  J.B. Yu;  J.X. Chen;  L. Liu;  X.J. Nie;  C.J. Ning
收藏  |  浏览/下载：14/0  |  提交时间：2022/01/18
Optimization Design of Four-Point Vibration Isolation Support for Spallation Neutron Source Vibration Magnet 会议论文
Brazil, 2021
作者:  J.S. Zhang, J.X. Chen;  H.Y. He;  L. Liu;  R.H. Liu;  C.J. Ning
收藏  |  浏览/下载：18/0  |  提交时间：2022/01/18
Design of the Two-Layer Girder for Accelerating Tube 会议论文
Brazil, 2021
作者:  X.J. Nie;  H.Y. He;  L. Kang;J.X. Chen;  L. Liu;  R.H. Liu
收藏  |  浏览/下载：31/0  |  提交时间：2022/01/18
Key Technologies for Remote Detection of CSNS Radiation Environment 会议论文
Australia, 2019
作者:  L. Kang;  R.H. Liu;  X.J. Nie;  A.X. Wang;  G.Y. Wang
收藏  |  浏览/下载：79/0  |  提交时间：2019/08/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：137/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace